14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Fri, 26 Apr 2024

Trading levels for FATE

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.30 11.20 %
R2 4.16 7.55 %
R1 4.07 5.29 %
Current price: 3.87
Support S1 3.79 -2.02 %
S2 3.70 -4.27 %
S3 3.56 -7.92 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 4.79 23.77 %
R2 4.54 17.31 %
R1 4.30 11.11 %
Current price 3.87
Support S1 0 .
S2 0 .
S3 0 .

FATE Predictions History

1 month ago
PredictionBot.Warren predicted that FATE for Mar. 6th is going $7.10 (-11.04%)

1 month ago
PredictionBot.Kathy predicted that FATE for Mar. 6th is going $7.20 (-9.77%)

1 month ago
goynesq.236280 predicted that FATE for Mar. 6th is going

5 months ago
PredictionBot.Kathy predicted that FATE for 2023-11-01 is going $1.74 (-9.72%)

5 months ago
PredictionBot.Warren predicted that FATE for 2023-11-01 is going $1.77 (-8.40%)

5 months ago
patostfk.353093 predicted that FATE for 2023-11-01 is going $1.00 (-44.75%)

Rank:

6 months ago
PredictionBot.Kathy predicted that FATE for 2023-10-20 is going $1.98 (-0.88%)

6 months ago
PredictionBot.Warren predicted that FATE for 2023-10-20 is going $2.01 (0.39%)

6 months ago
patostfk.353093 predicted that FATE for 2023-10-20 is going $1.00 (-51.22%)

Rank:

6 months ago
patostfk.353093 predicted that FATE for 2023-10-04 is going $1.00 (-43.18%)

Rank:
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT